Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
0.7824 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 13.476 | 23.367 | 18.52 | 29.688 | 8.76 | 0 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 65.242 | 65.242 |
| Cash and Short Term Investments
| 13.476 | 23.367 | 18.52 | 29.688 | 8.76 | 0 | 65.242 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.207 | 0.333 | 0.404 | 1.716 | 0.07 | 0 | 0 |
| Total Current Assets
| 14.683 | 23.7 | 18.924 | 31.404 | 8.76 | 0 | 65.242 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0.001 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.82 | 0 | 0 | 0 | 0.002 | 0.002 | 0 |
| Total Non-Current Assets
| 0.82 | 0 | 0 | 0 | 0.002 | 0.002 | 0 |
| Total Assets
| 15.503 | 23.7 | 18.924 | 31.404 | 8.762 | 0.003 | 65.242 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 6.283 | 3.849 | 3.52 | 0.51 | 1.008 | 0.225 | 0 |
| Short Term Debt
| 0.458 | 0 | 0 | 0 | 0 | 3.765 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 2.723 | 0 |
| Other Current Liabilities
| 7.86 | 13.326 | -1.001 | 1.326 | -0.683 | -0.123 | 0 |
| Total Current Liabilities
| 14.602 | 17.175 | 6.04 | 2.345 | 1.333 | 6.814 | 0 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.089 | 0.807 | 0.567 | 0.373 | 2.964 | 0 | 0 |
| Total Non-Current Liabilities
| 0.089 | 0.807 | 0.567 | 0.373 | 2.964 | 0 | 0 |
| Total Liabilities
| 14.691 | 17.982 | 6.607 | 2.718 | 1.333 | 6.814 | 6.086 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 29.07 | 0 |
| Common Stock
| 0.005 | 0.003 | 0.002 | 0.001 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -164.273 | -134.354 | -91.171 | -66.832 | -58.31 | -54.527 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -54.527 | 0 |
| Other Total Stockholders Equity
| 165.081 | 140.07 | 103.486 | 95.517 | 65.739 | 73.171 | 0 |
| Total Shareholders Equity
| 0.813 | 5.719 | 12.316 | 28.686 | 7.43 | -6.811 | 0 |
| Total Equity
| 0.813 | 5.719 | 12.316 | 28.686 | 7.43 | -6.811 | 0 |
| Total Liabilities & Shareholders Equity
| 15.503 | 23.7 | 18.924 | 31.404 | 8.762 | 0.003 | 65.242 |